Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.
暂无分享,去创建一个
Marek Langner | Kamila Sroda | M. Grzybek | M. Langner | A. Sikorski | A. Kozubek | Arkadiusz Kozubek | Aleksander F Sikorski | Michał Grzybek | Janusz Rydlewski | K. Sroda | J. Rydlewski
[1] W. Oyen,et al. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. , 2001, The Journal of pharmacology and experimental therapeutics.
[2] C. Alving,et al. Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs. , 1989, Journal of immunology.
[3] M. Mora,et al. SURFACE MODIFIED LIPOSOMES BY COATING WITH CHARGED HYDROPHILIC MOLECULES , 2000 .
[4] G. Betageri,et al. Drug encapsulation and release from multilamellar and unilamellar liposomes , 1992 .
[5] J. Cohen,et al. Sterically stabilized liposomes: physical and biological properties. , 1994, Journal of drug targeting.
[6] T. Ishida,et al. Accelerated clearance of PEGylated liposomes in rats after repeated injections. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[7] T. Allen,et al. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. , 1989, Biochimica et biophysica acta.
[8] T M Allen,et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.
[9] C. Alving,et al. Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens. , 1992, Biochimica et biophysica acta.
[10] J. Kamps,et al. The influence of repeated injections on pharmacokinetics and biodistribution of different types of sterically stabilized immunoliposomes. , 2003, Biochimica et biophysica acta.
[11] A. Gabizon,et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] N. Oku,et al. Long-circulating liposomes. , 1994, Critical reviews in therapeutic drug carrier systems.
[13] M. Bodó,et al. The interaction of liposomes with the complement system: in vitro and in vivo assays. , 2003, Methods in enzymology.
[14] A. Emili,et al. Enhanced antibody response to liposome-associated protein antigens: preferential stimulation of IgG2a/b production. , 1992, Vaccine.
[15] W. Oyen,et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. , 2000, The Journal of pharmacology and experimental therapeutics.
[16] A. Gabizon. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. , 1992, Cancer research.
[17] T. Allen. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.
[18] T. Allen,et al. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine. , 1992, Cancer research.
[19] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Bally,et al. Techniques for encapsulating bioactive agents into liposomes. , 1986, Chemistry and physics of lipids.
[21] A A Bogdanov,et al. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. , 1994, Biochimica et biophysica acta.
[22] C. Alving. Natural antibodies against phospholipids and liposomes in humans. , 1984, Biochemical Society transactions.
[23] M. Woodle,et al. Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.